Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQU9H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,473
Award facts
- Contract value 100% obligated
- $10,472.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,472.88 delivery order to Amerisourcebergen Drug Corp (Corporate Office division) on January 20, 2026, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitive, firm fixed-price award carries an ultimate completion date of January 21, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating open competition among qualified vendors. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor providing critical medical products to federal healthcare systems.
This delivery order falls under Amerisourcebergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, enabling the company to fulfill orders for military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The Ozempic delivery represents one of numerous task orders executed under this strategic global pharmaceutical support contract.
Quick answers
Who was awarded contract SPE2DR26FQU9H?
SPE2DR26FQU9H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FQU9H worth?
The government has obligated $10,473 on SPE2DR26FQU9H.
Is contract SPE2DR26FQU9H an order under another contract?
Yes. SPE2DR26FQU9H is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU9H competed?
The extent of competition for SPE2DR26FQU9H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award